Get the Stockscreener App
5.86
0.51%
0.00
Chromadex Corp stock is traded at $5.86, with a volume of 2.93M.
It is up +0.51% in the last 24 hours and up +74.26% over the past month.
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
See More
Previous Close:
$5.86
Open:
$5.72
24h Volume:
2.93M
Relative Volume:
3.37
Market Cap:
$445.02M
Revenue:
$83.57M
Net Income/Loss:
$-4.94M
P/E Ratio:
-65.11
EPS:
-0.09
Net Cash Flow:
$6.97M
1W Performance:
+60.49%
1M Performance:
+74.26%
6M Performance:
+55.82%
1Y Performance:
+297.97%
1-Day Range:
$5.36
$6.18
1-Week Range:
$3.49
$6.18
52-Week Range:
$1.32
$6.18
Chromadex Corp Stock (CDXC) Company Profile
Name
Chromadex Corp
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Oct-16-19 | Initiated | Oppenheimer | Outperform |
| Feb-14-19 | Initiated | B. Riley FBR | Buy |
| Nov-27-17 | Resumed | H.C. Wainwright | Buy |
| Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Chromadex Corp Stock (CDXC) Latest News
ChromaDex records 31% sales growth; stock PT raised to $8 by H.C. Wainwright - Investing.com
Are Investors Keen On Selling Holdings In Chromadex Corp (NASDAQ: CDXC)? - Stocks Register
BSW Wealth Partners Acquires Shares of 88,847 ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
Equities Analysts Issue Forecasts for ChromaDex Q2 Earnings - MarketBeat
ChromaDex (NASDAQ:CDXC) Issues Quarterly Earnings Results - MarketBeat
ChromaDex Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
ChromaDex stock soars to 52-week high, hits $4.69 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $4.69 - Investing.com India
ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates - MSN
ChromaDex Corp (CDXC) Q3 2024 Earnings: EPS of $0.02 Beats Estimates, Revenue Hits $25.6 Million - GuruFocus.com
ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
ChromaDex surges on surprise Q3 profit - XM
ChromaDex: Q3 Earnings Snapshot - New Haven Register
ChromaDex Reports Strong Q3 2024 Financial Results - TipRanks
ChromaDex Corporation Reports Third Quarter 2024 Financial Results - BioSpace
ChromaDex Shares Climb on Forecast for 15% Revenue Growth - MarketWatch
Chromadex Reports Strong Q3 2024 with 31% Sales Increase - TipRanks
ChromaDex reports Q3 EPS 2c, consensus 0c - TipRanks
ChromaDex sees FY24 revenue growth 15% - TipRanks
ChromaDex Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
Curious About NAD+? Here’s How It Works and How to Try It At Home - NewBeauty Magazine
ChromaDex Q3 2024 Earnings Preview - MSN
ChromaDex Corp (CDXC) Q3 2024 Earnings Report Preview: What To E - GuruFocus.com
Insights into ChromaDex's Upcoming Earnings - Benzinga
ChromaDex Co. (NASDAQ:CDXC) Sees Significant Drop in Short Interest - MarketBeat
$9M Fee Awarded For 'Feeble' Milk Vitamin Eligibility Row - Law360
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 - The Bakersfield Californian
ChromaDex (CDXC) Stock Price, News & Analysis - MarketBeat
ChromaDex (CDXC) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch - Yahoo Finance
ChromaDex to Participate in the 17th Annual LD Micro Main Event - The Bakersfield Californian
Are Medical Stocks Lagging ChromaDex (CDXC) This Year? - Yahoo Finance
Recent Insider Activity Could Benefit Chromadex Corp (CDXC) - Knox Daily
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) - StreetInsider.com
Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) – Company AnnouncementFT.com - Financial Times
ChromaDex parts with accountant over independence concerns By Investing.com - Investing.com South Africa
ChromaDex parts with accountant over independence concerns - Investing.com India
Marshall Wace LLP Acquires New Stake in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex Corp (CDXC) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges - Yahoo Finance
Rhumbline Advisers Purchases Shares of 45,519 ChromaDex Co. (NASDAQ:CDXC) - Defense World
Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year? - MSN
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference - The Bakersfield Californian
Two Polish men extradited to NI jailed for drugs offences - Ireland Live
A new experience centre in Bengaluru decodes whisky, gin, and heritage brews of India - Condé Nast Traveller India
Nu Republic launches Cyberstud X2 and Cyberstud X4 Firefly TWS in India - Techlomedia
XLRI JAMSHEDPUR’S PRODZION CLUB HOSTS ITS SECOND PRODUCT SYMPOSIUM: AURORA 2.0 - India Education Diary
Jharkhand News: XLRI Jamshedpur hosts product symposium Aurora - The Jharkhand Story
NI Courts Service awards £85M contract to Canadian IT firm CGI - Belfast Live
Nu Republic Unveils Cyberstud X2 and X4 Firefly Wireless Earbuds - Gadget Bridge
BMS alum Catherine Owen Adams to lead Acadia - BioCentury
Chromadex Corp Stock (CDXC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Chromadex Corp Stock (CDXC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Patrick Kristin | Director |
Aug 23 '24 |
Sale |
3.57 |
23,000 |
82,110 |
0 |
1.08%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):